期刊文献+

miR-551b-3p在胰腺癌细胞和组织中的表达及其临床意义 被引量:3

Expression of miR-551b-3p in pancreatic cancer cells and tissues and its role in progression of pancreatic cancer
下载PDF
导出
摘要 目的研究miR-551b-3p在胰腺癌细胞和组织中的表达,探讨其在胰腺癌发生发展中的临床意义。方法利用实时定量聚合酶链反应(RT-PCR)技术分别检测4种胰腺癌细胞和正常胰腺导管上皮细胞,以及76对胰腺癌组织和癌旁组织中miR-551b-3p的表达水平,并对miR-551b-3p的表达与胰腺癌患者临床病理学特征进行分析。结果 miR-551b-3p在PANC-1、Aspc-1、SW1990和Miapaca-2四种胰腺癌细胞中的相对表达量分别为(0.125±0.012)、(0.179±0.005)、(0.672±0.025)、(0.577±0.019),低于其在正常胰腺导管上皮细胞HPDE6C-7中的相对表达量,差异有统计学意义(P<0.05)。在胰腺癌组织和癌旁组织中miR-551b-3p的ΔCt值分别为(7.254±0.112)和(3.993±0.098),差异有统计学意义(P<0.001)。TNM分期Ⅰ、Ⅱ、Ⅲ和Ⅳ期胰腺癌组织中miR-551b-3p的ΔCt值分别为(4.343±0.032)、(5.325±0.112)、(6.987±0.098)和(9.132±0.212),差异有统计学意义(P<0.001)。有淋巴结转移和无淋巴结转移患者的胰腺癌组织中miR-551b-3p的ΔCt值分别为(8.492±0.021)和(6.676±0.103),差异有统计学意义(P=0.012)。高、中、低分化胰腺癌组织中miR-551b-3p的ΔCt值分别为(5.349±0.092)、(6.129±0.112)、(8.454±0.065),差异有统计学意义(P=0.002)。结论 miR-551b-3p的表达与胰腺癌的分化程度、淋巴结转移以及TNM分期相关。miR-551b-3p可能是提示胰腺癌临床进展的潜在标志物。 Objective This paper intends to analyze the correlation between the expression of miR-551b-3p and the clinicopathological characteristics in pancreatic cancer(PC).Methods The expression of miR-551b-3p was analyzed by quantitative real-time PCR(RT-PCR)in pancreatic cancer cells,normal pancreatic ductal epithelial cells,and 76 paired PC samples.The relation between miR-551b-3p expression and clinicopathological characteristics was analyzed.Results The relative expression of miR-551b-3p in PC cells were lower than that in normal pancreatic ductal epithelial cells [(0.125±0.012),(0.179±0.005),(0.672±0.025),(0.577±0.019)vs 1,P〈0.05].The relative expression of miR-551b-3p in PC tissues was also lower than that in peritumoral tissues [(7.254±0.112)vs(3.993±0.098),P〈0.001].The relative expression of miR-551b-3p in tumors with different TNM stages were in stages Ⅰ,Ⅱ,Ⅲ,and Ⅳ,with a significant difference among them [(4.343±0.032),(5.325±0.112),(6.987±0.098),(9.132±0.212),P〈0.001].There was a significant difference between the relative expression of miR-551b-3p in PC with lymph node invasion and without lymph node invasion[(8.492±0.021)vs(6.676±0.103),P=0.012].Different differentiation grades showed significantly different expression of miR-551b-3p[(5.349±0.092),(6.129±0.112),(8.454±0.065),P=0.002].Conclusions The expression of miR-551b-3p is correlated with the differentiation grade,the TNM stage and the lymph node invasion,which may be a potential biomarker for the progression of PC.
出处 《国际消化病杂志》 CAS 2016年第6期360-363,共4页 International Journal of Digestive Diseases
关键词 胰腺癌 miR-551b-3p 淋巴结转移 临床分期 Pancreatic cancer MiR-551b-3p Lymph node invasion TNM stage
  • 相关文献

参考文献13

二级参考文献173

  • 1潘博,郭俊超,廖泉,赵玉沛.吉西他滨与胰腺癌化疗耐药[J].中国普外基础与临床杂志,2005,12(5):530-532. 被引量:16
  • 2倪泉兴.胰腺癌的临床流行病学研究现况[J].胰腺病学,2006,6(2):65-68. 被引量:6
  • 3黄陈,裘正军,刘辰,孙红成.阻断STAT3信号转导通路对人胰腺癌细胞生长的影响[J].肿瘤,2006,26(5):414-417. 被引量:16
  • 4裘正军,黄陈,裘玮,曹俊,黄克俭,张放,朱麟,江弢.STAT3短发卡RNA表达载体对胰腺癌细胞增殖与凋亡的影响[J].中华普通外科杂志,2007,22(2):126-129. 被引量:10
  • 5Haura EB,Turksnn J,Jove R.Mechanisms of disease:Insights into the emerging role of signal transducers and activators of transcription in cancer.Nat Clin Pract Oncol,2005,2:315 -324.
  • 6Hannon GJ.RNA interference.Nature,2002,418:244-251.
  • 7Fahmy RG,Dass CR,Sun LQ,et al.Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.Nat Med,2003,9:1026-1032.
  • 8Huang C,Cao J,Huang KJ,et al.Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cell in vitro.Cancer Sci,2006,97:1417-1423.
  • 9Amin HM,McDonnell TJ,Ma Y,et al.Selective inhibition ofSTAT3 induces apoptosis and G (1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.0ncogene,2004,23:5426-5434.
  • 10Masuda M,Suzui M,Yasumatu R,et al.Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.Cancer Res,2002,62:3351-3355.

共引文献303

同被引文献27

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部